- Home
- OTEX vs ROIV Comparison
OTEX vs ROIV Comparison
Compare OTEX & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTEX
- ROIV
- Stock Information
- Founded
- OTEX 1991
- ROIV 2014
- Country
- OTEX Canada
- ROIV United Kingdom
- Employees
- OTEX N/A
- ROIV N/A
- Industry
- OTEX EDP Services
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- OTEX Technology
- ROIV Health Care
- Exchange
- OTEX Nasdaq
- ROIV Nasdaq
- Market Cap
- OTEX 8.9B
- ROIV 8.4B
- IPO Year
- OTEX 1998
- ROIV N/A
- Fundamental
- Price
- OTEX $33.97
- ROIV $11.82
- Analyst Decision
- OTEX Hold
- ROIV Strong Buy
- Analyst Count
- OTEX 6
- ROIV 10
- Target Price
- OTEX $38.80
- ROIV $17.39
- AVG Volume (30 Days)
- OTEX 359.4K
- ROIV 4.0M
- Earning Date
- OTEX 10-31-2024
- ROIV 11-11-2024
- Dividend Yield
- OTEX 3.10%
- ROIV N/A
- EPS Growth
- OTEX 207.36
- ROIV N/A
- EPS
- OTEX 1.71
- ROIV 5.65
- Revenue
- OTEX $5,769,577,000.00
- ROIV $158,303,000.00
- Revenue This Year
- OTEX N/A
- ROIV $53.59
- Revenue Next Year
- OTEX $2.70
- ROIV $26.91
- P/E Ratio
- OTEX $19.79
- ROIV $2.05
- Revenue Growth
- OTEX 28.64
- ROIV 101.44
- 52 Week Low
- OTEX $27.50
- ROIV $8.29
- 52 Week High
- OTEX $45.47
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- OTEX 59.57
- ROIV 47.60
- Support Level
- OTEX $33.35
- ROIV $11.52
- Resistance Level
- OTEX $33.96
- ROIV $12.08
- Average True Range (ATR)
- OTEX 0.49
- ROIV 0.22
- MACD
- OTEX -0.03
- ROIV -0.01
- Stochastic Oscillator
- OTEX 87.50
- ROIV 29.40
About OTEX Open Text Corporation
Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.